Earnings

AC Immune Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $3.994M Beat $1.000M Estimate

Nov 4, 2026 · 07:18 AM ET· updated 2h ago

AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. This is a 20 percent increase over losses of $(0.20) per share from the same

Why It Matters

AC Immune lost less money than experts predicted this quarter. When a company loses less than expected, it means operations are going better than people thought.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ACIU2.22

+0.13 (+6.22%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.